Valneva to Present its Chikungunya Vaccine Candidate at the ASTMH 2021 Annual Meeting

NEXT STORY
iBio Announces Collaboration with UT Southwestern to Investigate IBIO-100 in Solid Tumors
PREV STORY
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precision Therapeutics’ TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell Types, Initiating Its Proprietary Process for New Drug Development Via Patient-Derived Tumor Models

MINNEAPOLIS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or ...

author_avatar
NASDAQ Market News

Oncobiologics, Inc. to Present at the 2016 Cantor Fitzgerald 2nd Annual Healthcare Conference

CRANBURY, N.J., July 06, 2016 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

Onconova Announces Publication of Rigosertib Phase 3 ONTIME Data in Lancet Oncology

-- Online-First Publication Currently Available -- -- First Randomized Trial With Survival Endpoint in ...

author_avatar
NASDAQ Market News